Table 1 Clinical and biochemical characteristics of the study participants
From: Role of disturbed fatty acids metabolism in the pathophysiology of diabetic erectile dysfunction
Characteristics | Patients with VED (n = 72) | Patients w/o VED (n = 78) | Controls (n = 88) |
|---|---|---|---|
Clinical profile | |||
Age (years) | 57.7 ± 5.1 | 58.8 ± 4.8 | 55.9 ± 7.0 |
BMI (kg/m2) | 26.75 ± 4.8 | 27.43 ± 3.2 | 25.15 ± 3.8 |
Duration of T2D (years) | 10.95 ± 7.1 | 8.25 ± 5.4 | __ |
Duration of ED (years) | 3.30 ± 2.9 | __ | __ |
Biochemical profile | |||
Fasting Glucose (mmoL/L) | 9.87 ± 3.7** | 8.36 ± 2.1** | 5.27 ± 0.9 |
HbA1c (mmoL/mol) | 95** | 77** | 38 |
Insulin (μIU/mL) | 5.62 ± 3.6* | 4.93 ± 2.7* | 3.56 ± 2.4 |
HOMA IR | 2.39 ± 1.7** | 1.83 ± 1.1** | 0.83 ± 0.4 |
NO (ng/L) | 1.43 ± 1.18*** | 3.09 ± 1.85 | 3.30 ± 2.92 |
Serum lipid profile (mmoL/L) | |||
Total cholesterol | 4.54 ± 0.8* | 4.43 ± 0.8* | 4.06 ± 0.9 |
Triglycerides | 1.60 ± 0.9 | 1.77 ± 0.7* | 1.37 ± 0.5 |
LDLc | 2.70 ± 0.94* | 2.68 ± 0.9* | 2.27 ± 1,02 |
HDLc | 1.03 ± 0.3 | 0.94 ± 0.4 | 1.1 ± 0.4 |
Serum Hepatic profile (IU/L) | |||
AST | 23.19 ± 7.5 | 21.5 ± 8.4* | 24.28 ± 8.9 |
ALT | 20.26 ± 11.6* | 21.36 ± 10.4* | 25.01 ± 12.3 |